Halozyme Therapeutics, Inc. (HALO)

69.12 +0.24 (+0.36%) USD  |  NASDAQ  |  Dec 29, 15:50
More

Halozyme Therapeutics Average Basic Shares Outstanding (Quarterly)

Average Basic Shares Outstanding (Quarterly) Chart

View Average Basic Shares Outstanding (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Basic Shares Outstanding (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Basic Shares Outstanding (Quarterly) Range, Past 5 Years

View Average Basic Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Basic Shares Outstanding (Quarterly) Benchmarks

View Average Basic Shares Outstanding (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Protalix Biotherapeutics, Inc. Upgrade